contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


dignitana-ab-dignitana-launches-new-initiatives-to-support-reimbursement-and-market-access

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Dignitana is active in medical technology. The company's main focus is to develop, manufacture, and distribute medical aids that are primarily used as a scalp cooling system in chemotherapy treatment, where the purpose is to eliminate or greatly reduce hair loss. The company operates worldwide. Dignitana was founded in 2007 has its headquarters located in Lund.

Dignitana

Dignitana (http://www.dignitana.com), world leader in scalp cooling innovation, announced today the launch of two key initiatives to support reimbursement and insurance appeals for U.S. providers...

<div class="abstract">Dignitana&nbsp;(<a href="http://www.dignitana.com">http://www.dignitana.com</a>), world leader in scalp cooling innovation, announced today the launch of two key initiatives to support reimbursement and insurance appeals for U.S. providers of The DigniCap Scalp Cooling System. The company has engaged two Minneapolis-based organizations, medical device consulting firm JD Lymon Group&nbsp;(<a href="http://jdlymon.com">http://jdlymon.com</a>) and market access specialists JDL Access&nbsp;(<a href="http://Jdlaccess.com">http://Jdlaccess.com</a>), to launch a reimbursement hub and an appeal support program. JDL Access will be working directly with providers and payers to facilitate reimbursement for patient treatments using DigniCap. &nbsp;</div>"The JD Lymon team are recognized experts in reimbursement. As we approach the July 1 introduction of CPT codes for scalp cooling, we are acutely aware of the complexities of the reimbursement landscape. Our partnership with JD Lymon and JDL Access is a demonstration of our commitment to our customers to achieve and maintain access to DigniCap for patients in need,"&nbsp; said William Cronin, Dignitana CEO.&nbsp; "When the AMA announced the CPT codes for scalp cooling last fall, we initiated a plan to do our part to help the oncology community establish appropriate reimbursement. JDL Access and JD Lymon are the ideal partners to help us achieve that."Julie Grimme, President of JDL Access along with Jolayne Devers, Partner at JD Lymon, state, "We are honored to be selected by Dignitana to support their market needs. Emerging technologies face special challenges in reimbursement. We understand these challenges and look forward to a beneficial collaboration and increased access to The DigniCap Scalp Cooling System."With more than 70 combined years of medical device and pharmaceutical experience across the firm's partners, JDL Access and JD Lymon focuses on accelerating market access through multi-disciplinary strategies that address the complex interrelationship between policy, evidence, and practice to optimize the market position of emerging therapies.&nbsp;Cronin continued, "We have recently seen an accelerated pace in new providers signing on for DigniCap. With this increased activity and the developments in reimbursement, I believe awareness of scalp cooling and utilization of DigniCap will continue to grow, further advancing our company's overall strategic objectives and mission."The DigniCap&nbsp;Scalp Cooling System received FDA clearance in 2015 to minimize hair loss from chemotherapy in patients with solid tumors. DigniCap is available&nbsp;(<a href="http://www.dignicap.com/availability">http://www.dignicap.com/availability</a>) in 34&nbsp;U.S. states and in 40 countries around the world.

Dignitana AB: Dignitana launches new initiatives to support reimbursement and market access